Search In this Thesis
   Search In this Thesis  
العنوان
Comparative study between serum markers for fibrosis and interferon therapy in chronic hepatitis patients infected and non infected with bilharzias/
المؤلف
Abd El-Ghany, Gehan Mohamed Ahmed.
هيئة الاعداد
باحث / Gehan Mohamed Ahmed Abd El-Ghany
مشرف / Amal Abd EL Aziz
مشرف / Sabah Farouk EL-Abd,
مشرف / Naglaa Elsayd Rifaat Ismael
الموضوع
Molecular Biology.
تاريخ النشر
2013 .
عدد الصفحات
133 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
Molecular Biology
تاريخ الإجازة
1/6/2013
مكان الإجازة
اتحاد مكتبات الجامعات المصرية - Department of Molecular Biology.
الفهرس
Only 14 pages are availabe for public view

from 133

from 133

Abstract

HCV and schistosomiasis are the most serious health burden in Egyptian community. Aim: To test the accuracy of direct and indirect fibrosis biochemical markers for the assessment of hepatic fibrosis in patients with chronic hepatitis C virus (HCV) infection with and without Schistosomaisis compared to liver biopsy. Subjects and methods: patients with HCV candidate for anti viral therapy in National Egyptian Program for treatment of HCV were included in this study, all patients were investigated for serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, total bilirubin, prothrombin time and concentration, complete blood count, hepatitis B surface antigen (HBs Ag), HCV Abs, HCV-RNA by quantitative polymerase chain reaction, abdominal ultrasound and ultrasonic-guided liver biopsy. The following ratios, scores and indices were calculated and compared with the results of the histopathological examination: AST/ALT ratio (AAR), age platelet index (API), AST to platelet ratio index (APRI) and serum Hyaloronic acid (HA) before and after end of therapy. RESULTS: There is statistical significant association between HA and interferon response to treatment (p- value < 0.01). HAA is a good sensitive, bad specific to diagnose severe fibrosis or cirrhosis (73.9%, 66.7%). AST is a good sensitive, bad specific to diagnose severe fibrosis or cirrhosis (73.9, 49.1). HA/platelets ratio is a good sensitive, bad specific to diagnose severe fibrosis or cirrhosis (73.9%, 59.3%). There is no statistical significant difference between both HCV group with bilharsiasis and HCV mono-infection regarding HA (p- value > 0.05). There is no statistical significant association between HA and fibrosis grade in mono-infection (p- value > 0.05). There is statistical significant association between HA and fibrosis grade in HCV group with bilharsiasis (p value<0.01). There is highly statistical significant difference between basal and follow up of HA (p- value < 0.01). There is no statistical significant association between HA and activity grade in each group of HCV (p- value > 0.05).. There is statistical significant association between HA and response to interferon treatment in each group of HCV (p- value < 0.05).
CONCLUSION: The use of indirect and direct (HA) biomarkers may reduce the need for liver biopsy, HA could also predict the response to interferon in the studied patients either chronic HCV mono-infection or coinfected with HCV.
To
My Family,
Father Mother,
Uncles,
Brothers,